Skip to main content
GOODWILL E-HEALTH INFO CO., LTD. logo

GOODWILL E-HEALTH INFO CO., LTD. — Investor Relations & Filings

Ticker · 688246 ISIN · CNE1000055V0 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 569 across all filing types
Latest filing 2024-02-08 Legal Proceedings Report
Country CN China
Listing Shanghai Stock Exchange 688246

About GOODWILL E-HEALTH INFO CO., LTD.

https://www.bjgoodwill.com/

Goodwill E-Health Info Co., Ltd. specializes in the development and implementation of comprehensive healthcare information technology solutions. The company focuses on digitalizing clinical workflows through its core offerings, which include advanced Hospital Information Systems (HIS), Electronic Medical Record (EMR) systems, and Clinical Information Systems (CIS). Its product suite is designed to enhance hospital management efficiency, improve patient safety, and facilitate data-driven clinical decision-making. Goodwill E-Health also provides regional healthcare information platforms that enable data sharing and interoperability across multiple medical institutions. By leveraging big data and cloud computing, the company supports the construction of smart hospitals and integrated healthcare networks, catering primarily to large-scale medical centers and public health organizations seeking digital transformation.

Recent filings

Filing Released Lang Actions
嘉和美康关于股东咸宁市凯旋机会成长基金(有限合伙)收到北京证监局警示函的公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement regarding a regulatory warning letter issued by the Beijing Securities Regulatory Bureau to a shareholder of the company for violating disclosure rules related to share reduction. It details the regulatory action, the shareholder's response, and the company's statement on the matter. There are no financial statements, earnings data, or report publications. The content is a regulatory announcement about legal and compliance issues involving the company and its shareholder. This fits best under 'Legal Proceedings Report' (LTR) as it involves regulatory enforcement and legal compliance matters.
2024-02-08 Chinese
嘉和美康关于以集中竞价交易方式回购股份进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the progress of the company's share repurchase program through centralized bidding transactions. It provides details on the number of shares repurchased, prices, total amounts paid, and references to previous announcements about the repurchase plan. The document is short (1296 characters) and focuses on the update of share buyback activity rather than financial results or other report types. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2024-02-02 Chinese
嘉和美康关于2022年股票期权与限制性股票激励计划预留授予部分第一个行权期自主行权实施公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the implementation and exercise of a 2022 stock option and restricted stock incentive plan by the company 嘉和美康(北京)科技股份有限公司. It includes information about the approval process, the number of stock options granted and exercised, conditions for exercising stock options, adjustments, and legal and financial opinions related to the stock incentive plan. The document is not a full financial report, earnings release, or management discussion but rather a regulatory announcement about stock option exercises and related corporate actions. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about stock option exercise and related approvals, which aligns best with Regulatory Filings (RNS). The document length is 7558 characters, which is substantial but the content is focused on stock option exercise announcement and related approvals rather than a financial report or presentation. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-01-29 Chinese
嘉和美康关于使用部分闲置募集资金暂时补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement by 嘉和美康 (Jiahe Meikang) regarding the company's decision to temporarily use part of its idle raised funds to supplement working capital. It details the board and supervisory committee meetings approving this use, the amount involved, the purpose, and compliance with regulatory requirements. It references prior announcements and approvals, but does not contain financial statements or detailed financial performance data. The document is relatively short (2965 characters) and serves as a disclosure of a financing-related operational update rather than a full financial report or earnings release. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2024-01-25 Chinese
嘉和美康第四届监事会第十四次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of a resolution passed by the Supervisory Board (监事会) of 嘉和美康(北京)科技股份有限公司 regarding the temporary use of idle raised funds to supplement working capital. It includes details about the meeting date, attendance, legal compliance, the proposal reviewed, and the voting results. The document is short (760 characters) and is an official announcement of a board decision related to capital use, not a full financial report or audit. It does not contain financial statements or detailed financial data. This fits best under Capital/Financing Update (CAP) as it concerns the use of raised funds and capital management.
2024-01-25 Chinese
嘉和美康关于归还暂时用于补充流动资金的闲置募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company 嘉和美康 regarding the return of temporarily used idle raised funds that were used to supplement working capital. It references a prior board resolution and a previous announcement about the use of idle raised funds. The content focuses on the status and return of these funds, which relates to the company's capital management and financing activities. The document is short (700 characters) and is an announcement about capital usage and return, not a full financial report or detailed financial data. Therefore, it fits best under Capital/Financing Update (CAP).
2024-01-19 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.